MTaI is an association of research-based medical technology companies who have made remarkable investments by setting up large number of R&D centres and manufacturing plants in India. MTaI represents a wide spectrum of the medical device and equipment industry with global experience in innovation and manufacturing.
All the time stressing on the three hallmarks of healthcare – Quality, Consistency and Patient Safety, we want to be a responsible voice of the industry. We are committed to improving access to affordable and quality healthcare for patients… Read More
The Medical Technology Association of India (MTaI) has urged the policymakers to ensure quality of healthcare while policy decision-making New Delhi: The Medical Technology Association of India (MTaI) has called upon the government to ensure that common man has full...read more
NEW DELHI: The prices of all medical devices except for stents, condoms and intrauterine devices can only be raised by up to 10% in a year, the National Pharmaceutical Pricing Authority (NPPA) said in a new office order on Friday. The drug price regulator also...read more
Reduction in stent prices may unfavourably skew the market for the patient and will adversely affect the business environment, sectoral body MTaI has said. "The control of stent prices in the manner it has been done, with a shocking reduction of prices may unfavorably...read more
This budget has certainly brought a wide smile on the faces of people dealing with medical devices but fails on the other hand, it didn't back the government's vision to make India one of the top three pharmaceutical markets by 2020. While revealing his fourth budget,...read more
GUEST POST WRITTEN BY Sanjay Bhutani Mr. Bhutani is the India head for Bausch & Lomb and founding member of the Medical Technology Association of India. GST, the biggest tax reform in independent India, is on course to implementation and is set to change the way...read more
Apprehensions of the National Pharmaceutical Pricing Authority (NPPA) about the creation of an artificial shortage in stents appear to have come true. Major stent companies have been withdrawing the more expensive brands from hospitals claiming that they are doing it...read more